For the remaining genes, patients with both RNASeq and survival data were interrogated (N = 48) and SRSF1 was the only gene that correlated between both CN gain and mRNA over-expression at a p<0.05 (log-rank p = 0.008; Fig 3B) as well as between over-expression and survival using a Cox proportion hazard (PH) regression model adjusting for age, gender, tumor stage, and chemotherapy status (p = 0.047; HR = 2.7; Fig 3C). Here, SRSF1 is linked to neoplasm.